How do I contact Sander Slootweg?

Sander Slootweg, Managing Partner at Forbion, can be reached by email. The verified email address is listed on this page.

What is Sander Slootweg's email address?

Sander Slootweg's email address uses the forbion.com domain (shown as *****@forbion.com until revealed).

What does Sander Slootweg invest in?

Sander Slootweg backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Sander Slootweg?

Sander Slootweg backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Sander.

Where is Sander Slootweg based?

Sander Slootweg is based in Netherlands and works at Forbion.

Sander Slootweg Email & Contact Information

Managing Partner @ Forbion

Show Sander's email

Sander Slootweg Location

Netherlands

Sander Slootweg Investing

Co-owner and Managing Partner at Forbion

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Sander Slootweg Summary

Sander Slootweg, based in Netherlands, is a Managing Partner at Forbion. Sander Slootweg invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Sander Slootweg's verified email and contact details are available on Mintround.

How to cold email Sander Slootweg

Sander Slootweg, Forbion in Netherlands, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Sander:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Sander's verified address below. No warm intro required.

Show Sander's email

Notable investments

AzafarosSeries B · $150M · 2025
NorthSea TherapeuticsSeries C · $80M · 2021
New Amsterdam PharmaSeries A · $190M · 2021
Oxyrane UKSeries D · $27M · 2011

Frequently co-invests with

Dirk KerstenForbionEdward Van Wezel (BGV (BioGeneration Ventures))Gaurav GuptaAscendant BioCapitalMarco BoorsmaForbionOscar Slotboom (BGV (BioGeneration Ventures))Peter ThielFounders FundRob de Ree (BGV (BioGeneration Ventures))

Sander Slootweg's colleagues at Forbion

Rogier RooswinkelPartner, Forbion

Wouter JoustraGeneral Partner, Forbion

Antoine Boulanger PietteAssociate, Forbion

Audrey CacalySenior Associate, Forbion

Dmitrij HristodorovPartner, Forbion

Dirk KerstenGeneral Partner, Forbion

Geert-Jan MulderManaging Partner, Forbion

Holger ReithingerGeneral Partner, Forbion

Jasper BosGeneral Partner, Forbion

Marco BoorsmaGeneral Partner, Forbion

Martien van OschManaging Partner, Forbion

Nanna LuneborgGeneral Partner, Forbion

See all 13 at Forbion →

Similar investors

Diede BrunenSenior Associate, BGV (BioGeneration Ventures)

Audrey CacalySenior Associate, Forbion

Robin van BoxselPartner, FORWARD.one

Clement SalqueAnalyst, Bioqube Ventures